Deregulation of alternative processing of Calcitonin/CGRP-I pre-mRNA by a single point mutation.

Biochem Biophys Res Commun

Institute of Molecular Biology and Medical Biotechnology, University of Utrecht, The Netherlands.

Published: August 1991

The Calcitonin/CGRP-I (CALC-I) gene was one of the first examples of a cellular gene exhibiting alternative, tissue-specific processing of its primary transcript. Calcitonin (CT) mRNA is the predominant product in thyroid C-cells, whereas CGRP-I (Calcitonin Gene Related Peptide-I) mRNA is the main product in neurons of the central and peripheral nervous systems. Investigating the molecular mechanism underlying the alternative processing events, we have demonstrated that the CT-specific splice acceptor site is an intrinsical weak site due to usage of a uridine branch acceptor. The data presented in this report show that a single point mutation changing the uridine branch acceptor into a commonly preferred adenosine residue results in the predominant production of CT mRNA in otherwise CGRP-I mRNA-producing F9 cells. The results of the experiments implicate that the low efficiency of CT splicing, caused by usage of a uridine branch acceptor, allows the production of CGRP-I mRNA in neural cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0006-291x(91)90989-kDOI Listing

Publication Analysis

Top Keywords

uridine branch
12
branch acceptor
12
alternative processing
8
single point
8
point mutation
8
usage uridine
8
deregulation alternative
4
processing calcitonin/cgrp-i
4
calcitonin/cgrp-i pre-mrna
4
pre-mrna single
4

Similar Publications

Background: Protein-energy wasting, characterized by disordered body protein catabolism resulting from metabolic and nutritional derangements, is associated with adverse clinical outcomes in patients undergoing hemodialysis. Extended-hours hemodialysis (≥6 h per treatment session) offers both enhanced removal of uremic solutes and better fluid management, generally allowing more liberalized dietary protein and calorie intake. This study aimed to evaluate the difference in plasma metabolite profiles among patients receiving in-center daytime extended-hours hemodialysis and those receiving conventional hemodialysis.

View Article and Find Full Text PDF

Coronaviruses (CoVs) maintain large RNA genomes that frequently undergoes mutations and recombination, contributing to their evolution and emergence. In this study, we find that SARS-CoV-2 has greater RNA recombination frequency than other human CoVs. In addition, coronavirus RNA recombination primarily occurs at uridine (U)-enriched RNA sequences.

View Article and Find Full Text PDF

Apurinic/apyrimidinic endonuclease 1 (APE1) is responsible for the hydrolysis of the phosphodiester bond on the 5' side of an apurinic/apyrimidinic site during base excision repair. Moreover, in DNA, this enzyme can recognize nucleotides containing such damaged bases as 5,6-dihydro-2'-deoxyuridine (DHU), 2'-deoxyuridine (dU), alpha-2'-deoxyadenosine (αA), and 1,6-ethenoadenosine (εA). Previously, by pulsed electron-electron double resonance spectroscopy and pre-steady-state kinetic analysis, we have revealed multistep DNA rearrangements during the formation of the catalytic complex.

View Article and Find Full Text PDF

Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease.

Sci Transl Med

November 2024

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Article Synopsis
  • Development of broad-spectrum antiviral therapies, like 4'-fluorouridine (4'-FlU), is crucial for effectively responding to outbreaks and pandemics caused by emerging viruses, particularly those that cause hemorrhagic fevers, which have seen increasing morbidity and mortality rates.
  • 4'-FlU has shown antiviral activity against several hemorrhagic fever viruses in cell cultures and has demonstrated high efficacy in guinea pig models infected with lethal arenaviruses, maintaining its effectiveness at low doses.
  • When administered late in infection, 4'-FlU not only resolved clinical symptoms quickly but also showcased its potential as a therapeutic option with a broader application against various viral pathogens.
View Article and Find Full Text PDF

Viruses with broad tissue distribution and cell tropism successfully replicate in various nutrient environments in the body. Several viruses reprogram metabolism for viral replication. However, many studies focus on metabolic reprogramming in nutrient-rich conditions that do not recapitulate physiological environments in the body.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!